ClinicalTrials.Veeva

Menu

Vitamin D and Periodontitis

T

T.C. ORDU ÜNİVERSİTESİ

Status

Completed

Conditions

Alveolar Bone Loss

Treatments

Diagnostic Test: fasting venous blood samples

Study type

Observational

Funder types

Other

Identifiers

NCT03088488
OrduUniversity

Details and patient eligibility

About

Vitamin D has become important for periodontal disease due to play a role in autoimmunity, bone mineral metabolism and inflammation. Our aim was to investigate the relation between serum 25-hydroxy vitamin D levels, clinical periodontal parameters and blood serum biomarkers. The subjects were evaluated in 2 groups as chronic periodontitis (n= 30) and periodontally healthy subjects (n= 30). Periodontal parameters and fasting venous blood samples were taken from the subjects to assess each patient's periodontal status and for biochemical analyses (25-hydroxy vitamin D (25-OH vit D), osteoprotegerin (OPG), receptor activator of nuclear kappa B ligand (RANKL), C-telopeptide (CTx), tumor necrosis factor-α (TNF-α)).

Enrollment

60 patients

Sex

All

Ages

25 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

  • Inclusion Criteria:

    • never-smokers
    • no history of systemic disease
    • no patients had been under periodontal therapy and medicine for at least 6 months before the study
    • no pregnancy or lactation
    • no alcohol or antioxidant vitamin consumption.
  • Exclusion Criteria:

Trial design

60 participants in 2 patient groups

Periodontally healthy subjects
Treatment:
Diagnostic Test: fasting venous blood samples
Chronic periodontitis patients
Treatment:
Diagnostic Test: fasting venous blood samples

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems